Article summary
Earlier this year, Medibank, Australia’s largest private health insurer, announced a scheme where they dedicated $10 million to providing coverage for MDMA assisted therapy (MDMA-AT) for PTSD, in partnership with Emyria, to be provided via their Empax Centre. I reached out to both Medibank and Emyria, with a view to getting a clearer idea on what the costs for people getting this treatment would be.
Continue to the original publication for the complete article.